Company Logo Malaria was responsible for 597,000 deaths ... and cost-effective vaccine to prevent malaria is desperately needed. HDT Bio Corp. is a clinical-stage biopharmaceutical company ...

In addition to HDT Bio's technologies, the agreement provides MalarVx additional support from HDT to develop and commercialize malaria vaccines. This license expands the long-standing relationship ...

SEATTLE, Jan. 15, 2025 /PRNewswire/ -- MalarVx, Inc., a clinical-stage vaccine company, is proud to announce a license to HDT Bio's proprietary self-amplifying replicon RNA (repRNA) and lipid ...